Company Profiles

driven by the PitchBook Platform

Aniling

Description

Developer of DNA sequencing products. The company develops sequencing methods with applications in molecular data, genomics and epigenomics. The company is a spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC).

2014

Founded

PRIVATE

Status

1-10

Employees

Early Stage VC

Latest Deal Type

$207k

Latest Deal Amount

$207k

Total Amount Raised

Description

Developer of DNA sequencing products. The company develops sequencing methods with applications in molecular data, genomics and epigenomics. The company is a spin-off of the Institute of Predictive and Personalized Medicine of Cancer (IMPPC).

Website:

www.aniling.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Healthcare Technology Systems

Other Industries

Biotechnology

Primary Office

IMPPC, Ctra Can Ruti, Camí de les Escoles s/n 08916 BarcelonaSpain +34 93 554 3050
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Aniling's full profile, request a free trial.

Aniling Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Aniling Investors (1)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Caixa Capital RiscCorporate Venture Capital000 0000000 0000
Caixa Capital Risc Corporate Venture Capital

Aniling Executive Team (2)

NameTitleBoard
Seat
Contact
Info
Llorenç CollCo-Founder & Chief Executive Officer
Miguel Peinado Ph.DCo-Founder & Chief Scientific Officer
Llorenç Coll Co-Founder & Chief Executive Officer
Miguel Peinado Ph.D Co-Founder & Chief Scientific Officer

Aniling Board Members (1)

NameRepresentingRoleSinceContact
Info
Jaume Amat RieraSelfBoard Member000 0000
Jaume Amat Riera Board Member Self
Request full access to PitchBook